Inotropic and metabolic effects of dibutyryl cyclic adenosine 3', 5'-monophosphate in the perfused rat heart.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D004789:Enzyme Activation; D004791:Enzyme Inhibitors; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D006003:Glycogen / Q000032:analysis; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007773:Lactates / Q000096:biosynthesis; D009119:Muscle Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D010477:Perfusion; D010725:Phosphocreatine / Q000032:analysis; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats
D000227:Adenine Nucleotides; D002395:Catecholamines; D004791:Enzyme Inhibitors; D007773:Lactates; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D006003:Glycogen; D011433:Propranolol; D000242:Cyclic AMP; D004837:Epinephrine